Interestingly, TRPV2-expressing tumors evidenced the presence of several GFAP mononuclear-giant cells (MNGCs) resembling those found in GBM subtypes showing low proliferative rate and better prognosis [54,55,56,57]. This evidence concerns the gene TRPV2 and glioblastoma.